Presentation Efficacy, Safety of Rivaroxaban vs Warfarin in Elderly Patients with Nonvalvular A-fib Presenter: Jonathan L. Halperin June 09, 2014
Presentation Impact of Wait Times on the Effectiveness of TAVR in Severe Aortic Valve Disease Presenter: Harindra C. Wijeysundera June 09, 2014
Presentation TVT 2014 Postdilation After TAVR can be Guided Largely Using Hemodynamic Assessments Presenter: Jeffrey J. Popma June 07, 2014
Presentation TVT 2014 A Critical Analysis of Present Data on Cerebral Protection after TAVR Presenter: Axel Linke June 07, 2014
Presentation TVT 2014 Indications, Technique, and Results of Postdilation After CoreValve Presenter: Nicolas M. van Mieghem June 07, 2014
Presentation TVT 2014 Why Cerebral Protection after TAVR Will Become the Standard of Care Presenter: Eberhard Grube June 07, 2014
Presentation TVT 2014 Postdilation After TAVR: (1) When is it Indicated? (2) Is it Safe? (3) What are the Outcomes? Presenter: Rebecca T. Hahn June 07, 2014
Presentation TVT 2014 Why Cerebral Protection after TAVR Will be Used Sparingly (if at all) in the Future Presenter: Ganesh Manoharan June 07, 2014
Presentation TVT 2014 Perspectives on Predilation from an Experienced SAPIEN User Presenter: Raj Makkar June 07, 2014
Presentation TVT 2014 A Rationale Approach to Adjunct Pharmacotherapy After TAVR (With Stroke in Mind) Presenter: Susheel Kodali June 07, 2014